Martin Fuchs

FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases - The PARLIM trial (AIO KRK 0314).

K. Kaczirek, A. Kiani, M. Karthaus, 2022, European journal of cancer.